Fennec Pharmaceuticals’ (FENC) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Fennec Pharmaceuticals (NASDAQ:FENC – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $13.00 price target on the stock. HC Wainwright also issued estimates for Fennec Pharmaceuticals’ Q2 2025 earnings at ($0.07) EPS, Q3 2025 earnings at ($0.04) EPS, Q4 2025 […]
HC Wainwright restated their buy rating on shares of Fennec Pharmaceuticals (NASDAQ:FENC – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $13.00 price target on the stock. HC Wainwright also issued estimates for Fennec Pharmaceuticals’ Q2 2025 earnings at ($0.07) EPS, Q3 2025 earnings at ($0.04) EPS, Q4 2025 […]
